Loading...
Market
What will be the primary benefit cited by users of Starlink Direct-to-Cell by December 31, 2025?
2
Resolution / Starting Odds
Improved coverage • 25%
Faster data speeds • 25%
Lower cost • 25%
Other • 25%
Surveys and reports from technology analysts, user reviews
Story
FCC Approves SpaceX and T-Mobile's Starlink Direct-to-Cell Service to Eliminate Dead Zones
Nov 26, 2024, 09:11 PM
The Federal Communications Commission (FCC) has granted SpaceX conditional approval to use its Starlink satellites to provide direct-to-cellular services in the United States. This license for 'supplemental coverage from space' will enable SpaceX and T-Mobile to extend mobile coverage to remote areas and eliminate dead zones by allowing Starlink satellites to connect directly to existing LTE mobile phones. The service is expected to be available with existing LTE phones in a few weeks. The approval covers 7,500 second-generation (Gen2) satellites operating at lower orbits. SpaceX has already launched approximately 340 Starlink Direct to Cell satellites into orbit, positioning the company to commence the service. The collaboration aims to supplement T-Mobile's cellular network using SpaceX's satellite technology, potentially transforming mobile coverage across the nation.
View original story
Similar markets
Improved connectivity • 25%
Reliability • 25%
Cost-effectiveness • 25%
Ease of use • 25%
Improved service quality • 25%
Reduced latency • 25%
Environmental impact mitigation • 25%
Other • 25%
Emergency communications • 25%
Rural connectivity • 25%
Travel connectivity • 25%
Military applications • 25%
Rural connectivity • 25%
Emergency services • 25%
Maritime communications • 25%
Travel and tourism • 25%
Highly positive • 25%
Moderately positive • 25%
Neutral • 25%
Negative • 25%
Service reliability • 25%
Speed issues • 25%
Coverage limitations • 25%
Cost • 25%
Enhancing Starlink service • 25%
New service launch • 25%
Leasing to other companies • 25%
Other • 25%
Improved medical consultations • 25%
Enhanced communication with external aid • 25%
Improved patient record management • 25%
Other • 25%
U.S. only • 25%
U.S. and Japan • 25%
U.S., Japan, and New Zealand • 25%
More than three countries • 25%
Yes • 50%
No • 50%
